|
1
|
Ngamruengphong S and Patel T: Molecular
evolution of genetic susceptibility to hepatocellular carcinoma.
Dig Dis Sci. 59:986–991. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wu Y, Gan Y, Gao F, Zhao Z, Jin Y, Zhu Y,
Sun Z, Wu H, Chen T, Wang J, et al: Novel natural mutations in the
hepatitis B virus reverse transcriptase domain associated with
hepatocellular carcinoma. PLoS One. 9:e948642014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nischalke HD, Lutz P, Krämer B, Söhne J,
Müller T, Rosendahl J, Fischer J, Berg T, Hittatiya K, Fischer HP,
et al: A common polymorphism in the NCAN gene is associated with
hepatocellular carcinoma in alcoholic liver disease. J Hepatol.
61:1073–1079. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
van Bömmel F, Bartens A, Mysickova A,
Hofmann J, Krüger DH, Berg T and Edelmann A: Serum hepatitis B
virus RNA levels as an early predictor of hepatitis B envelope
antigen seroconversion during treatment with polymerase inhibitors.
Hepatology. 61:66–76. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Guirgis BS, Abbas RO and Azzazy HM:
Hepatitis B virus genotyping: Current methods and clinical
implications. Int J Infect Dis. 14:e941–e953. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xie JX, Zhao J, Yin JH, Zhang Q, Pu R, Lu
WY, Zhang HW, Wang HY and Cao GW: Association of novel mutations
and haplotypes in the preS region of hepatitis B virus with
hepatocellular carcinoma. Front Med China. 4:419–429. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Park YM, Jang JW, Yoo SH, Kim SH, Oh IM,
Park SJ, Jang YS and Lee SJ: Combinations of eight key mutations in
the X/preC region and genomic activity of hepatitis B virus are
associated with hepatocellular carcinoma. J Viral Hepat.
21:171–177. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu S, Zhang H, Gu C, Yin J, He Y, Xie J
and Cao G: Associations between hepatitis B virus mutations and the
risk of hepatocellular carcinoma: A meta-analysis. J Natl Cancer
Inst. 101:1066–1082. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen CH, Changchien CS, Lee CM, Tung WC,
Hung CH, Hu TH, Wang JH, Wang JC and Lu SN: A study on sequence
variations in pre-S/surface, X and enhancer II/core
promoter/precore regions of occult hepatitis B virus in non-B,
non-C hepatocellular carcinoma patients in Taiwan. Int J Cancer.
125:621–629. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang D, Ma S, Zhang X, Zhao H, Ding H and
Zeng C: Prevalent HBV point mutations and mutation combinations at
BCP/preC region and their association with liver disease
progression. BMC Infect Dis. 10:2712010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yin J, Xie J, Liu S, Zhang H, Han L, Lu W,
Shen Q, Xu G, Dong H and Shen J: Association between the various
mutations in viral core promoter region to different stages of
hepatitis B, ranging of asymptomatic carrier state to
hepatocellular carcinoma. Am J Gastroenterol. 106:81–92. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen QY, Harrison TJ, Sabin CA, Li GJ,
Huang GM, Yang JY, Wang XY, Li H, Liu MH and Fang ZL: The Effect of
HBV Genotype C on the Development of HCC Differs Between Wild-Type
Viruses and Those With BCP Double Mutations (T(1762)A(1764)). Hepat
Mon. 14:e162142014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yeh CT, So M, Ng J, Yang HW, Chang ML, Lai
MW, Chen TC, Lin CY, Yeh TS and Lee WC: Hepatitis B virus-DNA level
and basal core promoter A1762T/G1764A mutation in liver tissue
independently predict postoperative survival in hepatocellular
carcinoma. Hepatology. 52:1922–1933. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Su CW, Chiou YW, Tsai YH, Teng RD, Chau
GY, Lei HJ, Hung HH, Huo TI and Wu JC: The influence of hepatitis b
viral load and pre-s deletion mutations on post-operative
recurrence of hepatocellular carcinoma and the tertiary preventive
effects by anti-viral therapy. PLoS One. 8:e664572013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhu Y, Jin Y, Cai X, Bai X, Chen M, Chen
T, Wang J, Qian G, Gu J, Li J and Tu H: Hepatitis B virus core
protein variations differ in tumor and adjacent nontumor tissues
from patients with hepatocellular carcinoma. Intervirology.
55:29–35. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yan H, Yang Y, Zhang L, Tang G, Wang Y,
Xue G, Zhou W and Sun S: Characterization of the genotype and
integration patterns of hepatitis B virus in early- and late-onset
hepatocellular carcinoma. Hepatology. 61:1821–1831. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang XH and Wang PL: Relationship between
mutation on precore region of integrated HBV DNA and p53 gene
mutation in hepatocellular carcinoma. Ai Zheng. 22:715–718.
2003.(In Chinese). PubMed/NCBI
|
|
18
|
Chen CH, Changchien CS, Lee CM, Hung CH,
Hu TH, Wang JH, Wang JC and Lu SN: Combined mutations in
pre-s/surface and core promoter/precore regions of hepatitis B
virus increase the risk of hepatocellular carcinoma: A case-control
study. J Infect Dis. 198:1634–1642. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Qu LS, Liu TT, Jin F, Guo YM, Chen TY, Ni
ZP and Shen XZ: Combined pre-S deletion and core promoter mutations
related to hepatocellular carcinoma: A nested case-control study in
China. Hepatol Res. 41:54–63. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li MW, Hou W, Wo JE and Liu KZ: Character
of HBV (hepatitis B virus) polymerase gene rtM204V/I and rtL180M
mutation in patients with lamivudine resistance. J Zhejiang Univ
Sci B. 6:664–667. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu BM, Li T, Xu J, Li XG, Dong JP, Yan P,
Yang JX, Yan L, Gao ZY, Li WP, et al: Characterization of potential
antiviral resistance mutations in hepatitis B virus reverse
transcriptase sequences in treatment-naïve Chinese patients.
Antiviral Res. 85:512–519. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mirandola S, Sebastiani G, Rossi C, Velo
E, Erne EM, Vario A, Tempesta D, Romualdi C, Campagnolo D and
Alberti A: Genotype-specific mutations in the polymerase gene of
hepatitis B virus potentially associated with resistance to oral
antiviral therapy. Antiviral Res. 96:422–429. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lee HW, Chang HY, Yang SY and Kim HJ:
Viral evolutionary changes during tenofovir treatment in a chronic
hepatitis B patient with sequential nucleos(t)ide therapy. J Clin
Virol. 60:313–316. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Datta S, Ghosh A, Dasgupta D, Ghosh A,
Roychoudhury S, Roy G, Das S, Das K, Gupta S, Basu K, et al: Novel
point and combo-mutations in the genome of hepatitis B
virus-genotype D: Characterization and impact on liver disease
progression to hepatocellular carcinoma. PLoS One. 9:e1100122014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nakamura M, Kanda T, Nakamoto S, Haga Y,
Sasaki R, Jiang X, Yasui S, Arai M and Yokosuka O: Reappearance of
serum hepatitis B viral DNA in patients with hepatitis B surface
antigen seroclearance. Hepatology. 62:13292015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tseng TC, Liu CJ, Yang HC, Su TH, Wang CC,
Chen CL, Kuo SF, Liu CH, Chen PJ, Chen DS and Kao JH: High levels
of hepatitis B surface antigen increase risk of hepatocellular
carcinoma in patients with low HBV load. Gastroenterology.
142:1140–1149, .e3; quiz e13-4. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wu CY, Lin JT, Ho HJ, Su CW, Lee TY, Wang
SY, Wu C and Wu JC: Association of nucleos(t)ide analogue therapy
with reduced risk of hepatocellular carcinoma in patients with
chronic hepatitis B: A nationwide cohort study. Gastroenterology.
147:143–151.e5. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wong JS, Wong GL, Tsoi KK, Wong VW, Cheung
SY, Chong CN, Wong J, Lee KF, Lai PB and Chan HL: Meta-analysis:
The efficacy of anti-viral therapy in prevention of recurrence
after curative treatment of chronic hepatitis B-related
hepatocellular carcinoma. Aliment Pharmacol Ther. 33:1104–1112.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sinn DH, Lee J, Goo J, Kim K, Gwak GY,
Paik YH, Choi MS, Lee JH, Koh KC, Yoo BC, et al: Hepatocellular
carcinoma risk in chronic hepatitis B virus-infected compensated
cirrhosis patients with low viral load. Hepatology. 62:694–701.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Glebe D and Bremer CM: The molecular
virology of hepatitis B virus. Semin Liver Dis. 33:103–112. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Avellón A and Echevarria JM: Frequency of
hepatitis B virus ‘a’ determinant variants in unselected Spanish
chronic carriers. J Med Virol. 78:24–36. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gong L, Han Y, Chen L, Liu F, Hao P, Sheng
J, Li XH, Yu DM, Gong QM, Tian F, et al: Comparison of
next-generation sequencing and clone-based sequencing in analysis
of hepatitis B virus reverse transcriptase quasispecies
heterogeneity. J Clin Microbiol. 51:4087–4094. 2013. View Article : Google Scholar : PubMed/NCBI
|
